Inotek Pharmaceuticals have initiated a Phase I trial with its selective Adenosine 1 agonist INO-8875 for the treatment of glaucoma.
Filed under: Uncategorized | Tagged: adenosine 1, agonist, INO-8875, INO8875, Inotek, phase I | Leave a Comment »
Inotek commence Phase I trial with adenosine 1 agonist INO-8875
Posted on June 18, 2008 by crimsoncanary
BMS to begin Phase II trial of CCR2 Antagonist BMS-741672 in Insulin Resistance
Posted on June 18, 2008 by crimsoncanary
BMS are preparing to initiate a Phase II trial of CCR2 Antagonist BMS-741672 in Insulin Resistance. The trial will start in August 2008
Filed under: gpcr | Tagged: antagonist, BMS, BMS-741672, BMS741672, CCR-2, CCR2, phase II | Leave a Comment »
Elixirs Ghrelin agonist EX-1314 enhances gastric motility in vivo
Posted on June 18, 2008 by crimsoncanary
Data presented at the Endocrine Society meeting show Elixir Pharmaceutical’s ghrelin agonist, EX-1314 to enhance gastrointestinal motility in vivo
Filed under: gpcr | Tagged: agonist, Elixir, EX-1314, EX1314, ghrelin, Preclinical, Research | Leave a Comment »
Tranzymes Ghrelin Agonist TZP-102 completes phase I trial
Posted on June 18, 2008 by crimsoncanary
